Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
Lending
Lending
Go PRO Now
Open App
Success
Alert
Please select a Day.
Info

Nectar Lifesciences Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs
Add to

29/100
14.80
0.63 (4.45%)

As on 21 Nov, 2025 | 03:57

Open Trading A/c
Day Range
13.90
15.30
L H
52 Week Range
13.05
44.41
L H
Volume
972,964
*
i

* BSE Market Depth (21 Nov 2025)

BUY SELL
QTY PRICE PRICE QTY
450 14.66 14.93 414
5140 14.65 15.00 1000
2693 14.62 15.05 20
30 14.55 15.09 10
1 14.49 15.10 5
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
29/100
14.80
0.66 (4.67%)

As on 21 Nov, 2025 | 04:01

Open Trading A/c
Day Range
13.89
15.20
L H
52 Week Range
13.25
44.90
L H
Volume
114,123
*
i

* BSE Market Depth (21 Nov 2025)

BUY SELL
QTY PRICE PRICE QTY
450 14.66 14.93 414
5140 14.65 15.00 1000
2693 14.62 15.05 20
30 14.55 15.09 10
1 14.49 15.10 5
0 Total Total 0
Bid / Ask
0.00 / 0.00
Advance Chart
NSE
MC Essentials
47% Pass
MC Technicals
i
This represents current trend.Click here for disclaimer.
MC Insights

Low Financial Strength, Low Growth Trend Stock at Discounted Valuations

Financials
    Ownerships
      Industry Comparison
        Others
          Open 14.10
          Previous Close 14.17
          Volume 972,964.00
          Value (Lacs) 144.00
            VWAP 14.65
          Beta
          Mkt Cap (Rs. Cr.) 332
          High 15.30
          Low 13.90
          UC Limit 17.00
          LC Limit 11.33
          52 Week High 44.41
          52 Week Low 13.05
          Face Value 1.00
          All Time High 60.90
          All Time Low 7.10
          20D Avg Volume 626,228
          20D Avg Delivery(%) 43.27
          Book Value Per Share 42.63
          Dividend Yield 0.00
          TTM EPS See historical trend -16.12
          TTM PE See historical trend -- (Average PE)
          P/B See historical trend 0.35 (Low P/B)
          Sector PE 39.94

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          Forecast                                                

          Earnings Forecast

          Actuals Estimates
          ANNUALLY 
          (Rs.) 

          Valuations

          Consensus Recommendations

          • Buy
          • Outperform
          • Hold
          • Underperform
          • Sell

          Hits/Misses

          QUARTERLY (Rs.)
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline
          # of Beats
          # of Misses
          # of Inline

          MC Insights

          Stock Score

          29/100
          Low Financial Strength, Low Growth Trend Stock at Discounted Valuations

          Get detailed analysis with Moneycontrol Stock Insights.

          Get detailed analysis with Moneycontrol Stock Insights.

          Price
          • 66.67% away from 52 week high

          Financials
          Piotroski Score
          i

          indicates

          Industry Comparison
          • Market Cap - Below Median

          Shareholding Pattern
          • Promoter holding remains unchanged at 44.53% in Jun 2025 qtr.

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          ` Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          See Detail
          Historical Rating
          Moving Averages --
          Technical Indicators --
          Moving Averages Crossovers --

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -          		 S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          		--%
          1 Month
          		--%
          3 Months
          		--%
          YTD
          		--%
          1 Year
          		--%
          3 Years
          		--%
          Volume Analysis
          • Volume
          • Delivery

          SEASONALITY ANALYSIS

          11 out of 17 years Nectar Lifesciences has given negative returns in November.

          Month Max. Positive Change(%) Avg. Positive Change(%) Max. Negative Change(%) Avg. Negative Change(%) Average Change(%)
          November 28.23% (2023) 13.77% -18.94% (2011) -7.38% 0.08%
          Seasonality Analysis

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Nectar Life

          What's your call on Nectar Life today?

          Read 2 investor views

          BUY SELL HOLD
          POST

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          11 Jul, 2025

          L7 Hitech Private Limited

          Qty 1805000 Price 19.97 % Traded 0.81
          11 Jul, 2025

          Share India Securities Limited

          Qty 1380641 Price 20.26 % Traded 0.63
          11 Jul, 2025

          Share India Securities Limited

          Qty 1360641 Price 20.23 % Traded 0.62
          11 Jul, 2025

          L7 Hitech Private Limited

          Qty 85100 Price 20 % Traded 0.04
          10 Jul, 2025

          Hrti Private Limited

          Qty 1923031 Price 17.61 % Traded 0.78
          10 Jul, 2025

          Share India Securities Limited

          Qty 1833874 Price 18.61 % Traded 0.78
          10 Jul, 2025

          Hrti Private Limited

          Qty 1785217 Price 17.6 % Traded 0.72
          10 Jul, 2025

          Share India Securities Limited

          Qty 1713874 Price 18.83 % Traded 0.74

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          + Show More

          Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          (Rs. Cr)
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Detailed Financials

          Shareholding

          Summary
          See Top Holdings
          Trend

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          Nectar Life 14.80 4.45 331.91 - 0.35 -11.88 -56.83 -113 1,669 0.61
          Sun Pharma 1,779.70 0.13 427,009.64 40.87 5.91 15.13 -0.02 10,980 52,578 0.03
          Divis Labs 6,373.00 -1.38 169,183.13 68.08 11.30 14.63 6.62 2,191 9,360 0.00
          Torrent Pharma 3,686.50 -0.94 124,767.91 58.30 16.63 25.17 18.84 1,911 11,516 0.40
          Cipla 1,511.80 -1.14 122,118.85 22.44 3.91 16.90 3.16 5,291 27,547 0.00
          + See More

          About the Company

          Nectar Lifesciences Ltd. (NLL) is a knowledge driven organization which constitutes a vital part of fast growing Indian Pharmaceutical Industry. In a short span of existence, NLL has today emerged as 365 ranked organization amongst the top 500 Indian Corporates & is currently among top 25 fore runners of the Indian Pharmaceutical industry with a top 5 ranking in the Indian Bulk Drug Industry from a stand alone Active Pharmaceutical Ingredients (API Manufacture) perspective.
          {"success":1,"data":{"address":{"address1":"Village Saidpura,","address2":"Tehsil Derabassi,,Distt. S.A.S. Nagar,","city":"Mohali","state":"Punjab","pincode":"140507","telephone1":"01762-534001","telephone2":"","fax1":"01762-531833","fax2":"","email":"cs@neclife.com","web":"http:\/\/www.neclife.com"},"management":[{"name":"Sanjiv Goyal","designation":"Chairman & Managing Director"},{"name":"Surulichamy Senethilkumar","designation":"Director - R & D"},{"name":"Indu Pal Kaur","designation":"Independent Director"},{"name":"Meena Verma","designation":"Nominee Director"},{"name":"Rupinder Tewari","designation":"Independent Director"}],"registrars":{"name":"KFIN Technologies Pvt. Ltd.","address1":"Selenium Tower B, Plot No. 31-32,","address2":"Gachibowli, Financial District, \nNanakramguda,Seri","address3":"","address4":"","telephone":"040-67161500, 67162222, 33211000","fax":"040-23420814, 23001153","email":"einward.ris@karvy.com","internet":"http:\/\/www.kfintech.com","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"},{"name":"Nifty 200","value":"No"}],"details":{"bseId":"532649","nseId":"NECLIFE","series":"EQ","isinid":"INE023H01027"}}}

          • Registered Office

            • Address

              Village Saidpura,,Tehsil Derabassi,,Distt. S.A.S. Nagar,

            • City

              Mohali

            • State

              Punjab

            • Pin Code

              140507

            • Tel. No.

              01762-534001

            • Fax No.

              01762-531833

            • Email

              cs@neclife.com

            • Internet

              http://www.neclife.com

          • Registrars

            • Address

              Selenium Tower B, Plot No. 31-32,,Gachibowli, Financial District, Nanakramguda,Seri

            • City

              Hyderabad 500032

            • State

              Telangana

            • Tel. No.

              040-67161500, 67162222, 33211000

            • Fax No.

              040-23420814, 23001153

            • Email

              einward.ris@karvy.com

            • Internet

              http://www.kfintech.com

          • Management

            • Sanjiv Goyal

              Chairman & Managing Director

            • Surulichamy Senethilkumar

              Director - R & D

            • Indu Pal Kaur

              Independent Director

            • Meena Verma

              Nominee Director

            • Rupinder Tewari

              Independent Director

            + See More

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

            • Nifty 200

              No

          • Details

            • BSE:

              532649

            • NSE:

              NECLIFE

            • Series

              EQ

            • ISIN

              INE023H01027

          Go to Top
          Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347